For further details see:
Top Biotech Opportunities for the End-of-Year Run (CRSP, ATRX, PTPI, ALNA, MRNA, VRTX, IBB)For further details see:
Top Biotech Opportunities for the End-of-Year Run (CRSP, ATRX, PTPI, ALNA, MRNA, VRTX, IBB)Market Wire News is a media platform, the information on this page was provided by Wall Street PR News via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
Petros Pharmaceuticals Inc. Company Name:
PTPI Stock Symbol:
Market:
Lemonaid Health will offer customers more affordable access to branded ED medication STENDRA that may be taken as early as ~15 minutes prior to sexual activity (100mg and 200mg strengths only) [1] Please see Important Safety Information and study design below NEW YORK, NY / ACCESSWIRE ...
SUNNYVALE, Calif., May 14, 2024 (GLOBE NEWSWIRE) -- Lemonaid Health, Inc., a subsidiary of 23andMe Holding Co., (Nasdaq: ME), and a leading telemedicine provider, is now offering Petros Pharmaceuticals, Inc.’s (Nasdaq: PTPI), prescription erectile dysfunction (ED) medication STENDRA ...
--News Direct-- Petros Pharmaceuticals CEO Fady Boctor joined Steve Darling from Proactive to share exciting developments with Proactive, highlighting a new collaboration with Lemonaid Health, a prominent telemedicine provider and subsidiary of 23andMe. Through this collaboration, Lemonai...